Literature DB >> 2863348

Effect of age on the hepatic clearance of propranolol in rats.

K Iwamoto, J Watanabe, K Araki, N Deguchi, H Sugiyama.   

Abstract

The effect of age on hepatic clearance of propranolol was investigated in male Wistar rats (3 to 104 weeks old). Pharmacokinetic analysis of the plasma propranolol data obtained after i.v. dosage (1.0 mg kg-1) indicated that both the elimination rate constant and the volume of distribution decreased with age between weeks 5 and 11, after when the distribution volume remained almost constant. The elimination rate constant was reduced consistently with age after 15 weeks. Total body clearance of the drug was reduced extensively with age between weeks 5 and 11 (94 to 43 ml min-1 kg-1) and decreased gradually thereafter. The plasma free fraction of propranolol also decreased with age, falling from more than 20% in 3 to 5 weeks-old rats to about 10% in rats of 52 to 104 weeks. In immature rats the renal clearance was approximately 5 to 12% of the total body clearance. Intrinsic hepatic clearance for unbound propranolol also decreased with age between weeks 7 and 24. As expected from the evidence that propranolol has a high extraction ratio, the extent of its hepatic clearance was significantly dependent on the liver blood flow. These data suggest that the age-dependent decrease in hepatic clearance of propranolol is largely due to a reduction of the elimination rate that might be accompanied by the age-dependent decrease in liver blood flow.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863348     DOI: 10.1111/j.2042-7158.1985.tb03041.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats.

Authors:  N Yata; T Toyoda; T Murakami; A Nishiura; Y Higashi
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

2.  Continuous blood withdrawal as a rapid screening method for determining clearance of oral bioavailability in rats.

Authors:  W G Humphreys; M T Obermeier; R A Morrison
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

3.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

4.  Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.

Authors:  K W Woodhouse; H A Wynne
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

5.  Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding.

Authors:  K Hanada; S Akimoto; K Mitsui; K Mihara; H Ogata
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

6.  Influence of cancer cachexia on drug liver metabolism and renal elimination in rats.

Authors:  Katja Cvan Trobec; Mojca Kerec Kos; Jurij Trontelj; Iztok Grabnar; Anika Tschirner; Sandra Palus; Stefan D Anker; Jochen Springer; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03       Impact factor: 12.910

7.  Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.

Authors:  Shuyao Wang; Chun Chen; Chi Guan; Liping Qiu; Lei Zhang; Shaofeng Zhang; Hongyu Zhou; Hongwen Du; Chen Li; Yaqiong Wu; Hang Chang; Tao Wang
Journal:  Pharmacol Res Perspect       Date:  2021-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.